When was NantBio founded?

NantBio was founded in 2014 and raised its 1st funding round within a year of its incorporation.

Where is NantBio located?

NantBio is headquartered in Culver City, United States.

Who is the current CEO of NantBio?

Patrick Soon-Shiong of NantBio. They are also angel investors in 3 startups.

Is NantBio a funded company?

NantBio is a funded company, having raised a total of $105M across 4 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Jan 02, 2014.

When was the latest funding round of NantBio?

NantBio's latest funding was a $***** Series B round on Jun 01, 2015, with participation from 0 investor. Its primary sector is Biopharma Outsourcing. In United States, the Biopharma Outsourcing sector has seen $420M in funding in 2026 to date.

Where does NantBio rank among its competitors?

NantBio ranks 13th amongst 109 active competitors, of which 12 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Hyku Biosciences, which secured $6.6M in Dec, 2025.

Who are the top competitors of NantBio?

NantBio's top competitors include Taizhou Baiying Biotechnology, Sanyou Biopharmaceuticals and Biolexis Therapeutics. Among them, Hyku Biosciences secured the most recent funding round in December, 2025.

NantBio - 2026 Company Profile, Team, Funding & Competitors

Company Details

Website: nantbio.com
Email ID: *****@nantbio.com
Part Of

Key Metrics

Founded Year

2014

Location

Culver City, United States

Stage

Series B

Total Funding

$105M in 4 rounds

Latest Funding Round

Series B, Jun 01, 2015, $*****

Ranked

13^th among 109 active competitors

Similar Companies

Taizhou Baiying Biotechnology & 124 more

View NantBio's full profile

NantBio has raised a total funding of $105M over 4 rounds. Its first funding round was on Jan 02, 2014.

Here is the list of recent funding rounds of NantBio:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 01, 2015	9124846	Series B	1487478	3807206	3969918	6398832
Feb 06, 2015	7515325	Series B	4912312	9550308	3893857	9681906
Oct 24, 2014	2510667	Series A	7805104	4972963	5519422	9558614

Access funding benchmarks and valuations. Sign up today!

View details of NantBio's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NantBio include Taizhou Baiying Biotechnology, Sanyou Biopharmaceuticals and Biolexis Therapeutics. Here is the list of Top 10 competitors of NantBio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Taizhou Baiying Biotechnology 2012, Taizhou (China), Series B	Provider of antibody-drug research and development services	-	Haitong Bank, CoStone Capital & 10 others	48/100
2nd	Sanyou Biopharmaceuticals 2015, Shanghai (China), Series B	CRO focused on providing cell and molecular biology services for antibody drug discovery	-	LH Ventures, Haier & 3 others	45/100
3rd	Biolexis Therapeutics 2021, Salt Lake City (United States), Series A	CRO focused on drug discovery of small molecule therapeutics	$12.5M	Clarke Capital Partners	41/100
4th	Hyku Biosciences 2023, Lexington (United States), Seed	Covalent medicines platform for expanding the boundaries of drug discovery	$62.6M	RA Capital Management, Novartis Venture Fund ... & 4 others	39/100
5th	Procognia 2000, Rehovot (Israel), Public	Contract research services for glycosylation and protein function studies	$23.8M	Apax, SCP Vitalife & 2 others	35/100
6th	FerroptoCure 2022, Chiyoda City (Japan), Series A	Provider of ferroptosis drug discovery and development solutions	$3.12M	Tokyo Tech, Tokyo University of Science Innovation Capital ... & 8 others	34/100
7th	Systemic Bio 2022, Houston (United States), Unfunded	Provider of drug discovery & development services for cell lines and stem cells	-	-	33/100
8th	Capital Biosciences 2006, Gaithersburg (United States), Funding Raised	Provider of cell and molecular biology-based products and services	-	Business Innovation Network, HHS	30/100
9th	Cytorum 2020, Santa Clara (United States), Funding Raised	Provider of single cell analysis services using cytometry-based platforms	-	HHS	29/100
10th	Sunsai Pharma Equipments 2006, Thane (India), Unfunded	Manufacturer of pharmaceutical processing equipment	-	-	29/100
13th	NantBio 2014, Culver City (United States), Series B	Provider of drug discovery and development services for molecular biology services	$105M	-	28/100